CM
NTLA icon

Caption Management’s Intellia Therapeutics NTLA Stock Holding History

Caption Management’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.15M Buy
479,900
+434,900
+966% +$5.54M 0.04% 471
2025
Q4 		$405K Sell
45,000
-154,800
-77% -$2.13M ﹤0.01% 1273
2025
Q3 		$3.45M Buy
199,800
+164,800
+471% +$2.03M 0.03% 624
2025
Q2 		$328K Hold
35,000
– – ﹤0.01% 1195
2025
Q1 		$249K Sell
35,000
-25,000
-42% -$253K ﹤0.01% 1231
2024
Q4 		$700K Sell
60,000
-32,100
-35% -$501K 0.01% 999
2024
Q3 		$1.89M Buy
92,100
+67,100
+268% +$1.55M 0.03% 579
2024
Q2 		$560K Sell
25,000
-21,000
-46% -$500K 0.01% 788
2024
Q1 		$1.27M Buy
46,000
+8,500
+23% +$236K 0.02% 673
2023
Q4 		$1.14M Sell
37,500
-7,500
-17% -$216K 0.02% 772
2023
Q3 		$1.42M Sell
45,000
-15,000
-25% -$582K 0.02% 671
2023
Q2 		$2.45M Hold
60,000
– – 0.04% 446
2023
Q1 		$2.24M Sell
60,000
-7,500
-11% -$294K 0.04% 419
2022
Q4 		$2.36M Sell
67,500
-50,000
-43% -$2.38M 0.04% 519
2022
Q3 		$6.57M Buy
117,500
+92,500
+370% +$5.74M 0.09% 267
2022
Q2 		$1.29M Sell
25,000
-168,900
-87% -$8.58M 0.02% 789
2022
Q1 		$14.1M Buy
+193,900
New +$16.4M 0.17% 141
2021
Q3 		– Sell
-439,000
Closed -$71.1M – 1698
2021
Q2 		$71.1M Buy
439,000
+273,000
+164% +$21.3M 0.93% 8
2021
Q1 		$13.3M Buy
+166,000
New +$11.1M 0.29% 73

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Caption Management's NTLA Position: Q1 2026 in Review

Caption Management sold out of Intellia Therapeutics (NTLA) in Q1 2026, closing a stake of 20,000 shares — an estimated $255K sold.

Caption Management first reported a position in NTLA in Q1 2021 and held it in 15 quarters. The position peaked at $3.03M in Q1 2021. 302 funds tracked by Wall St. Rank hold NTLA as of Q1 2026.

  • Caption Management reported no remaining Intellia Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 20,000 Intellia Therapeutics shares in Q1 2026, an estimated $255K.
  • Caption Management first reported a position in Intellia Therapeutics in Q1 2021 and held it in 15 quarters.
  • Caption Management's Intellia Therapeutics position peaked at $3.03M in Q1 2021.
  • 302 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.